BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. It has a 2023 impact factor of 5.4.[1] It is published by Adis International (SpringerNature).
| Discipline | Drug therapy, pharmacology |
|---|---|
| Language | English |
| Edited by | Kathy Fraser |
| Publication details | |
| History | 1994-present |
| Publisher | Adis International (Springer Nature) (New Zealand) |
| Frequency | Bimonthly |
| Hybrid | |
| 5.807 (2020) | |
| Standard abbreviations | |
| ISO 4 | BioDrugs |
| Indexing | |
| CODEN | BIDRF4 |
| ISSN | 1173-8804 (print) 1179-190X (web) |
| Links | |
References
edit
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |